Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium therapy, hypercalcemia, and hyperparathyroidism.

M E Wolf1, M Moffat, J Mosnaim

  • 1Mental Health Services, Veterans Affairs Medical Center, North Chicago, IL 60064, USA.

American Journal of Therapeutics
|July 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a pathway for children disclosing potential for self-harm.

International journal of paediatric dentistry·2023
Same author

A Guide for Clinicians supporting Women and Families navigating Surrogacy.

Irish medical journal·2023
Same author

Experiences of medical practitioners in the Australian Defence Force on live tissue trauma training.

BMJ military health·2020
Same author

Physiotherapists have a vital part to play in combatting the burden of noncommunicable diseases.

Physiotherapy·2014
Same author

Risk scores for transient ischemic attack.

Frontiers of neurology and neuroscience·2013
Same author

Antithrombotic therapy in transient ischemic attack patients.

Frontiers of neurology and neuroscience·2013
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
Same journal

Dose-Dependent Escitalopram-Induced Anejaculation and Anorgasmia: Rapid Reversal After Discontinuation and Bupropion Therapy.

American journal of therapeutics·2026
Same journal

Critical Appraisal of "Continued versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: A Meta-Analysis".

American journal of therapeutics·2026
See all related articles

Long-term lithium treatment for bipolar disorder can cause hypercalcemia and parathyroid gland hyperplasia. This increases the risk of cardiac arrhythmias, necessitating regular monitoring for patients on lithium therapy.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Lithium is a widely used mood stabilizer for bipolar disorder.
  • It affects calcium metabolism in multiple organs, including the brain, kidneys, and heart.
  • Long-term lithium use can lead to adverse effects, including hypercalcemia.

Observation:

  • A patient on long-term lithium therapy developed hypercalcemia, hypertension, and severe bradyarrhythmia.
  • Endocrine workup revealed hyperparathyroidism with biochemical findings distinct from primary hyperparathyroidism, suggesting direct lithium effects on the kidney.
  • Parathyroid gland hyperplasia was confirmed surgically.

Findings:

  • Lithium-induced hypercalcemia is associated with hyperparathyroidism and parathyroid hyperplasia.

Related Experiment Videos

  • Discontinuation of lithium did not resolve the biochemical abnormalities.
  • Cardiac arrhythmias, particularly bradycardia and conduction defects, were observed in other patients with lithium-induced hypercalcemia.

    • Implications:

    • Lithium therapy can lead to significant endocrine and cardiac complications.
    • Hypercalcemia in patients on lithium increases the risk of cardiac arrhythmias.
    • Regular laboratory and electrocardiographic monitoring are crucial for patients on maintenance lithium therapy.